Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alter

Showing results (611-620 of 660) with videos related to

Pageof 66
Sort By:
British Journal of Pharmacology|July 2, 2010
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolaseL Thors, J J Burston, B J Alter, et al.
Hepatology (Baltimore, Md.)|November 24, 2012
Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners studyNorah A Terrault, Jennifer L Dodge, Edward L Murphy, et al.
The New England Journal of Medicine|September 27, 1973
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnelT L Lewis, H J Alter, T C Chalmers, et al.
The New England Journal of Medicine|December 31, 1992
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study GroupL B Seeff, Z Buskell-Bales, E C Wright, et al.
Science (New York, N.Y.)|April 15, 2000
The outcome of acute hepatitis C predicted by the evolution of the viral quasispeciesP Farci, A Shimoda, A Coiana, et al.
JAMA|November 7, 1990
Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infectionM J Alter, S C Hadler, F N Judson, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|December 13, 2006
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adultsEric E Mast, Cindy M Weinbaum, Anthony E Fiore, et al.
Plos Pathogens|March 28, 2025
Selection and characterization of a broadly neutralizing class of HCV anti-E2 VH1-69 antibodiesAndreas Soerensen, Filip Popovic, Christina Holmboe Olesen, et al.
Annals of Internal Medicine|April 1, 1986
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated bloodD E Koziol, P V Holland, D W Alling, et al.
Journal of Clinical Microbiology|September 5, 2015
An Epidemiologic Investigation of a Case of Acute Hepatitis ESouvik Sarkar, Elenita M Rivera, Ronald E Engle, et al.
Pageof 66

Showing results (611-620 of 660) with videos related to

Sort By:
Pageof 66
British Journal of Pharmacology|July 2, 2010
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolaseL Thors, J J Burston, B J Alter, et al.
Hepatology (Baltimore, Md.)|November 24, 2012
Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners studyNorah A Terrault, Jennifer L Dodge, Edward L Murphy, et al.
The New England Journal of Medicine|September 27, 1973
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnelT L Lewis, H J Alter, T C Chalmers, et al.
The New England Journal of Medicine|December 31, 1992
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study GroupL B Seeff, Z Buskell-Bales, E C Wright, et al.
Science (New York, N.Y.)|April 15, 2000
The outcome of acute hepatitis C predicted by the evolution of the viral quasispeciesP Farci, A Shimoda, A Coiana, et al.
JAMA|November 7, 1990
Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infectionM J Alter, S C Hadler, F N Judson, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|December 13, 2006
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adultsEric E Mast, Cindy M Weinbaum, Anthony E Fiore, et al.
Plos Pathogens|March 28, 2025
Selection and characterization of a broadly neutralizing class of HCV anti-E2 VH1-69 antibodiesAndreas Soerensen, Filip Popovic, Christina Holmboe Olesen, et al.
Annals of Internal Medicine|April 1, 1986
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated bloodD E Koziol, P V Holland, D W Alling, et al.
Journal of Clinical Microbiology|September 5, 2015
An Epidemiologic Investigation of a Case of Acute Hepatitis ESouvik Sarkar, Elenita M Rivera, Ronald E Engle, et al.
Pageof 66